Authors


Adam J. Horn, MD

Latest:

Early Access to Electronic Health Records May Influence the Patient Experience

In a recent Hot Topics column, Mehmet Sitki Copur, MD, FACP, et al discussed the pros and cons of patients receiving test results early through electronic medical records.


Pornchai Jonglertham, MD

Latest:

Locally Advanced Rectal Cancer, What is the Standard of Care?

A 39-year-old Hispanic male presented with complaints of mucous stools, loss of appetite, rectal bleeding and a 30-pound weight loss within the past several months.


Kristina Frinzi Byers, PharmD, BCOP

Latest:

Management of Neutropenic Toxicity From CDK4/6 Inhibitors

An oncology pharmacist discusses how to manage neutropenic toxicity from treatment with CDK4/6 inhibitors for HR-positive breast cancer.


Omar Alhalabi, MD

Latest:

Current and Future Landscape of Immune Checkpoint Inhibitors in Urothelial Cancer

In this review, we discuss known data and the differences between the different immune checkpoint inhibitors, as well as future avenues to explore with immuno-oncologic agents in urothelial cancer.


Amishi Y. Shah, MD

Latest:

Current and Future Landscape of Immune Checkpoint Inhibitors in Urothelial Cancer

In this review, we discuss known data and the differences between the different immune checkpoint inhibitors, as well as future avenues to explore with immuno-oncologic agents in urothelial cancer.


Carmen Bergom, MD, PhD

Latest:

Using Radiation Therapy to Reduce Recurrence in DCIS

Cancer Network spoke with Dr. Carmen Bergom about advancements in the treatment of DCIS and the importance of using local recurrence patterns to help guide future research.


Hirva Mamdani, MD

Latest:

Adjuvant Durvalumab Beneficial in Esophageal/GEJ Cancer?

Cancer Network spoke with Dr. Hirva Mamdani about the role and efficacy of adjuvant durvalumab in patients with Esophageal/GEJ Cancer.


Ahmed Kaseb, MD

Latest:

Perioperative Immunotherapy the Future of HCC Treatment?

Cancer Network spoke with Dr. Ahmed Kaseb about a phase II pilot trial of perioperative immunotherapy for resectable HCC and how the results could change future perioperative treatment of the disease.


Daniela Molena, MD

Latest:

Endoscopic Resection Brings Excitement to Esophageal Cancer Treatment

Cancer Network spoke with Dr. Daniela Molena about the advancements in the treatment of esophageal cancer, including the safety and importance of endoscopic resection for the disease.


Bassel El-Rayes, MD

Latest:

The Next Steps Beyond Cytotoxic Chemo in Pancreatic Cancer

Cancer Network spoke with Dr. Bassel El-Rayes about novel strategies on the horizon for pancreatic cancer during the 2019 ASCO Gastrointestinal Cancers Symposium.


Michael F. Holick, MD, PhD

Latest:

Does Vitamin D Have a Role in Cancer Prevention?

Cancer Network spoke with Dr. Michael Holick about the role of and effectiveness of vitamin D in cancer prevention.


Christine C. Davis, PharmD, BCOP

Latest:

Nausea and Vomiting: Managing Side Effects From PARP Inhibitors

Here, two oncology pharmacists discuss the side effects of PARP inhibitor treatment, and how to prevent and treat nausea and vomiting in this patient population.


Sarah Caulfield, PharmD, BCOP

Latest:

Nausea and Vomiting: Managing Side Effects From PARP Inhibitors

Here, two oncology pharmacists discuss the side effects of PARP inhibitor treatment, and how to prevent and treat nausea and vomiting in this patient population.


Edward A. Copelan, MD

Latest:

CAR T-Cell Therapy in Non-Hodgkin Lymphoma Patients

Dr. Copelan discusses the use of chimeric antigen receptor (CAR) T-cell therapy in non-Hodgkin lymphoma patients and how these therapies might improve upon the current standard of care.


Ebtesam Ahmed, PharmD, MS

Latest:

Antidepressants in Patients With Advanced Cancer: When They’re Warranted and How to Choose Therapy

In this article, we discuss the importance of screening for depression in cancer patients, as well as the available treatment options and their pros and cons.


Austin Lunney, BS

Latest:

Incidental Primary Squamous Cell Carcinoma of the Kidney Within a Calyceal Diverticulum Associated With Nephrolithiasis

A 64-year-old man is diagnosed with primary squamous cell carcinoma within the upper pole calyceal diverticulum of the kidney. What are the best steps of management?


Irfan Warraich, MD

Latest:

Incidental Primary Squamous Cell Carcinoma of the Kidney Within a Calyceal Diverticulum Associated With Nephrolithiasis

A 64-year-old man is diagnosed with primary squamous cell carcinoma within the upper pole calyceal diverticulum of the kidney. What are the best steps of management?


Joerg Herrmann, MD

Latest:

Detecting Cardiotoxicity in Cancer Patients Receiving VEGF Inhibitors

Dr. Herrmann discusses how to monitor and treat cardiotoxicity in cancer patients receiving VEGF inhibitors.


Reid Thompson, MD, PhD

Latest:

Artificial Intelligence in Oncology: Current Applications and Future Directions

In this review, we introduce the fundamentals of artificial intelligence and provide an overview of its current applications, pitfalls, and future directions in oncology.


Adam Dicker, MD, PhD

Latest:

Artificial Intelligence in Oncology: Current Applications and Future Directions

In this review, we introduce the fundamentals of artificial intelligence and provide an overview of its current applications, pitfalls, and future directions in oncology.


Sanjay Aneja, MD

Latest:

Artificial Intelligence in Oncology: Current Applications and Future Directions

In this review, we introduce the fundamentals of artificial intelligence and provide an overview of its current applications, pitfalls, and future directions in oncology.


Benjamin H. Kann, MD

Latest:

Artificial Intelligence in Oncology: Current Applications and Future Directions

In this review, we introduce the fundamentals of artificial intelligence and provide an overview of its current applications, pitfalls, and future directions in oncology.


Mehmet Sitki Copur, MD, FACP

Latest:

Leveraging Community Setting Multidisciplinary Care in Pancreatic Cancer

Genetic consultation and next-generation sequencing can also complement treatment strategies for patients with pancreatic cancer.


Shaila Merchant, MD

Latest:

Using Genetics to Determine Disparities in Gastric Cancer

Cancer Network spoke with Dr. Shaila Merchant about the difficulty in determining and linking the many disparities in gastric cancer and how genetic research can help.


Richard Gray, MSc

Latest:

Prolong Adjuvant Aromatase Inhibitor Therapy in Breast Cancer?

Cancer Network spoke with Richard Gray, MSc, about the effects of prolonging adjuvant aromatase inhibitor therapy has on breast cancer patients.


Gwendolyn Thomas

Latest:

Exercise Effects on Depressive Symptoms in Cancer Patients

Cancer Network speaks with an exercise physiologist about the benefits of physical activity for depressed and anxious cancer patients. 


Maggie Bedillion

Latest:

Exercise Effects on Depressive Symptoms in Cancer Patients

Cancer Network speaks with an exercise physiologist about the benefits of physical activity for depressed and anxious cancer patients. 


Joseph Unger, PhD, MS

Latest:

Decreasing Clinical Trial Participation Barriers

Cancer Network speaks with Joseph Unger, PhD, about ways to decrease the barriers for cancer patients to enroll in clinical trials.


Derek A. Wainwright, PhD

Latest:

Newly Diagnosed Glioblastoma: A Review on Clinical Management

This review focuses on clinical developments and management of newly diagnosed glioblastoma, and includes a discussion about the incorporation of molecular features into the classification of this disease.


Erik Ladomersky, PhD

Latest:

Newly Diagnosed Glioblastoma: A Review on Clinical Management

This review focuses on clinical developments and management of newly diagnosed glioblastoma, and includes a discussion about the incorporation of molecular features into the classification of this disease.